PICCIN, LUISA
 Distribuzione geografica
Continente #
NA - Nord America 269
EU - Europa 82
AS - Asia 67
AF - Africa 1
SA - Sud America 1
Totale 420
Nazione #
US - Stati Uniti d'America 269
IT - Italia 52
CN - Cina 38
SG - Singapore 16
IN - India 12
DE - Germania 6
FI - Finlandia 5
IE - Irlanda 3
UA - Ucraina 3
BE - Belgio 2
ES - Italia 2
FR - Francia 2
SE - Svezia 2
BR - Brasile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GB - Regno Unito 1
HK - Hong Kong 1
NL - Olanda 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 420
Città #
Fairfield 34
Houston 26
Chandler 21
Ashburn 18
Beijing 18
Padova 15
Ogden 14
Cambridge 13
San Diego 13
Pune 10
Woodbridge 10
Seattle 9
Singapore 8
Wilmington 7
Arezzo 5
Rome 5
Cagliari 4
Des Moines 4
Helsinki 4
Medford 4
New York 4
Princeton 4
Ann Arbor 3
Dublin 3
Kharkiv 3
Roxbury 3
Vigonza 3
Arzignano 2
Barcelona 2
Brussels 2
Guangzhou 2
Los Angeles 2
Pieve di Cento 2
Treviso 2
Tricesimo 2
Americana 1
Cairo 1
Casatenovo 1
Cittadella 1
Codogno 1
Dolna Tizina 1
Exton 1
Groningen 1
Hamburg 1
Hebei 1
Kilburn 1
Kolkata 1
Lappeenranta 1
Larino 1
Legnaro 1
Milan 1
Mountain View 1
Nanchang 1
Novara 1
Olomouc 1
Portland 1
Santa Clara 1
Selvazzano Dentro 1
Strasbourg 1
Totale 305
Nome #
Sex and interleukin-6 are prognostic factors for autoimmune toxicity following treatment with anti-CTLA4 blockade 120
Circulating biomarkers and risk of immune-related adverse events (irAEs) in patients (pts) with advanced non-small cell lung cancer (aNSCLC) and metastatic melanoma (mMel) 53
Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features 33
RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study 31
Merkel Cell Carcinoma: Evaluation of the Clinico-Pathological Characteristics, Treatment Strategies and Prognostic Factors in a Monocentric Retrospective Series (n=143) 30
Circulating cytokines as predictors of response to immune checkpoint inhibitors (ICIs) in patients (pts) with melanoma (Mel) and non–small cell lung cancer (NSCLC) 26
[Amelanotic acral melanoma originating from the foot: a clinical case.] 23
IL-8, S100 and IL-10 as indipendent predictors of response and survival in melanoma-patients treated with immune checkpoint inhibitors: preliminary results of an observational prospective study 20
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach 15
Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients 13
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 13
TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions 12
Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer 12
Germ cell tumors in male patients without gonadal involvement: computed tomography/magnetic resonance imaging findings and diagnostic workflow 12
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists 12
Molecular Modeling Unveils the Effective Interaction of B-RAF Inhibitors with Rare B-RAF Insertion Variants 10
Investigating the Retained Inhibitory Effect of Cobimetinib against p.P124L Mutated MEK1: A Combined Liquid Biopsy and in Silico Approach 7
Totale 442
Categoria #
all - tutte 3.383
article - articoli 3.294
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 4 0 0 2 2 2 3 2 2 3 2 0
2020/202149 1 0 0 5 0 3 3 8 5 15 9 0
2021/202276 1 9 0 5 10 2 22 2 1 1 8 15
2022/202386 7 4 0 5 20 16 0 5 13 4 10 2
2023/2024194 7 20 16 17 19 20 27 9 30 6 11 12
2024/20253 3 0 0 0 0 0 0 0 0 0 0 0
Totale 442